Agoracom

I've been reading a number of the recent posts and I think the truth is somewhere in between (as it usually is)...

someone had made suggestions that management had been selling off. You don't know that. You may or may not be right on that point. I'm more curious if someone could actually be shorting it or a convertible debenture financing thing is happening which is diluting the stock. Again we don't know that either.

Don't forget, if someone is selling at 2 cents... someone is buying it at 2 cents as well. Who is buying? what do they know?

Someone else had been suggesting that Scott hadn't been saying much about the Grayling news. Why would they? Why would company A ever promote company B? It's a rebranding thing. To my understanding Scott is simply taking Grayling's ClearCalm and is putting their name on it. Why would Scott ever promote that? Scott is an industry leader with a signifianct market share and Grayling can sell their product into that area.

Grayling is also a pink sheet company. Don't forget that. I would like to see it move to the otc to be a fully reporting company. If you want fully reporting companies, that's where you should be looking for small cap investments.

The bottom line in my view: Does Grayling have a legitimate product? In my view, yes. Is their growth potential? Again, yes. Is it worth 2 cents a share? Your call in terms of risk vs reward.

glta.